We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




European Market for Non-Invasive Blood Pressure Monitoring

By HospiMedica staff writers
Posted on 30 Jun 2008
The European market for non-invasive blood pressure monitoring is witnessing steady growth as a result of improving awareness of the health risks of high blood pressure (BP). More...
These are the latest findings from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

There is now a greater acknowledgement of the need to be vigilant against abnormal BP levels, increasing the practice of self-monitoring among the general public. As a result, market participants need to provide efficient sphygmomanometers at lower prices for home use. However, this increased demand is a double-edged sword; while prices of aneroid and digital sphygmomanometers in Europe have dropped due to the increasing presence of sphygmomanometers imported from Chinese or Korean manufacturers, the increased competition has not only impacted on profitability, but also on the intentions of market participants to invest in research and development in order to bring about product innovation. A symbiotic relationship between the established companies and new market participants will help in cutting cost and increasing the market share of the companies.

"Thanks to educational programs and general physician advice, people are making a move towards preventive healthcare to avoid the consequences of hypertension,” said Frost & Sullivan research analyst Akanksha Joshi. "This trend is making blood pressure a household concern, hence providing ample opportunities in the home care market for blood pressure monitoring.”

"Furthermore, environmental issues relating to use of mercury in measuring devices has led to its ban in many European countries, impacting the market share of mercury sphygmomanometers,” added Ms. Joshi. "Given this, companies need to focus on developing accurate blood pressure monitors that can surpass mercury sphygmomanometers as the standard.”

Among the product segments, sphygmomanometers account for the maximum revenues, followed by automated blood pressure monitors and ambulatory blood pressure monitors. The sphygmomanometers market is forecast to grow at a compound annual rate of 8.8% between 2007 and 2014, with market revenues for aneroid and digital sphygmomanometers increasing considerably. Frost & Sullivan has found that the European non-invasive BP monitors market earned revenues of over US$252 million in 2007 and estimates this to reach $444 million in 2014.


Related Links:
Frost & Sullivan

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.